Literature DB >> 24236458

The molecular basis of notch signaling regulation: a complex simplicity.

R Palermo, S Checquolo, D Bellavia, C Talora, I Screpanti1.   

Abstract

The Notch receptors have attracted considerable attention for their ability to control cellular functions that regulate embryo development and tissue homeostasis. Notch receptors act by controlling the expression of a specific set of target genes. If Notch signaling system can be so simple, and yet so complex in its pleiotropic effects, then a sophisticated network of regulatory mechanisms is required to maintain the control over the initiation, activity and termination of this signaling pathway. A multitude of regulatory mechanisms has been discovered that controls the interaction of Notch receptors with their ligands, the assembling of a Notch transcriptional activation complex and the termination of Notch signals. The intracellular and extracellular domains of the Notch receptors are synthesized as single proteins, pairing with each other during their trafficking through the exocytotic route. The mechanisms operating in the phase preceding the generation of the heterodimeric signal-competent Notch receptors can be as elaborate and physiologically important as those operating downstream of Notch receptor activation. These regulatory mechanisms, which are essential to understand the role of Notch signaling in human physiology and pathology are reviewed here.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24236458     DOI: 10.2174/1566524013666131118105216

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  12 in total

Review 1.  Lung cancer stem cells-origin, characteristics and therapy.

Authors:  D Prabavathy; Y Swarnalatha; Niveditha Ramadoss
Journal:  Stem Cell Investig       Date:  2018-03-14

2.  Original Research: Featured Article: Imatinib mesylate (Gleevec) inhibits Notch and c-Myc signaling: Five-day treatment permanently rescues mammary development.

Authors:  Robert Callahan; Barry A Chestnut; Ahmed Raafat
Journal:  Exp Biol Med (Maywood)       Date:  2016-08-21

3.  Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation.

Authors:  F De Falco; R Sabatini; F Falzetti; M Di Ianni; P Sportoletti; S Baldoni; B Del Papa; I Screpanti; P Marconi; E Rosati
Journal:  Leukemia       Date:  2014-11-26       Impact factor: 11.528

4.  Chalcones and Chalcone-mimetic Derivatives as Notch Inhibitors in a Model of T-cell Acute Lymphoblastic Leukemia.

Authors:  Deborah Quaglio; Nadezda Zhdanovskaya; Gloria Tobajas; Viviana Cuartas; Silvia Balducci; Michael S Christodoulou; Giancarlo Fabrizi; Marta Gargantilla; Eva-María Priego; Álvaro Carmona Pestaña; Daniele Passarella; Isabella Screpanti; Bruno Botta; Rocco Palermo; Mattia Mori; Francesca Ghirga; María-Jesús Pérez-Pérez
Journal:  ACS Med Chem Lett       Date:  2019-02-26       Impact factor: 4.345

5.  Identification of a novel chalcone derivative that inhibits Notch signaling in T-cell acute lymphoblastic leukemia.

Authors:  Mattia Mori; Luca Tottone; Deborah Quaglio; Nadezda Zhdanovskaya; Cinzia Ingallina; Marisa Fusto; Francesca Ghirga; Giovanna Peruzzi; Maria Elisa Crestoni; Fabrizio Simeoni; Francesca Giulimondi; Claudio Talora; Bruno Botta; Isabella Screpanti; Rocco Palermo
Journal:  Sci Rep       Date:  2017-05-19       Impact factor: 4.379

6.  Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression.

Authors:  G Franciosa; G Diluvio; F Del Gaudio; M V Giuli; R Palermo; P Grazioli; A F Campese; C Talora; D Bellavia; G D'Amati; Z M Besharat; C Nicoletti; C W Siebel; L Choy; A Rustighi; G Del Sal; I Screpanti; S Checquolo
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

7.  NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest.

Authors:  Giulia Diluvio; Francesca Del Gaudio; Maria Valeria Giuli; Giulia Franciosa; Eugenia Giuliani; Rocco Palermo; Zein Mersini Besharat; Maria Gemma Pignataro; Alessandra Vacca; Giulia d'Amati; Marella Maroder; Claudio Talora; Carlo Capalbo; Diana Bellavia; Saula Checquolo
Journal:  Oncogenesis       Date:  2018-05-25       Impact factor: 7.485

Review 8.  Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.

Authors:  Fokhrul Hossain; Samarpan Majumder; Deniz A Ucar; Paulo C Rodriguez; Todd E Golde; Lisa M Minter; Barbara A Osborne; Lucio Miele
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

9.  Stem cell properties of peripheral blood endothelial progenitors are stimulated by soluble CD146 via miR-21: potential use in autologous cell therapy.

Authors:  Amel Essaadi; Marie Nollet; Anaïs Moyon; Jimmy Stalin; Stéphanie Simoncini; Laure Balasse; Alexandrine Bertaud; Richard Bachelier; Aurélie S Leroyer; Gabrielle Sarlon; Benjamin Guillet; Françoise Dignat-George; Nathalie Bardin; Marcel Blot-Chabaud
Journal:  Sci Rep       Date:  2018-06-20       Impact factor: 4.379

Review 10.  Notch3 Targeting: A Novel Weapon against Ovarian Cancer Stem Cells.

Authors:  Simona Ceccarelli; Francesca Megiorni; Diana Bellavia; Cinzia Marchese; Isabella Screpanti; Saula Checquolo
Journal:  Stem Cells Int       Date:  2019-01-06       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.